This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Silver proteinate is a nasal decongestant and antiseptic of the nasal and ear canals.
- Generic Name
- Silver proteinate
- DrugBank Accession Number
- DB16362
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Argyrol
- Proteinated silver
- Silver protein
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination to treat Bacterial rhinitis Combination Product in combination with: Ephedrine levulinate (DB15988) •••••••••••• •••••••• • ••••• Used in combination to treat Catarrh Combination Product in combination with: Ephedrine levulinate (DB15988) •••••••••••• •••••••• • ••••• Used in combination to treat Inflammatory reaction caused by susceptible bacterial infections of the mucous membranes Combination Product in combination with: Ephedrine levulinate (DB15988) •••••••••••• •••••••• • ••••• Used in combination to treat Laryngitis Combination Product in combination with: Ephedrine levulinate (DB15988) •••••••••••• •••••••• • ••••• Treatment of Nasal congestion ••• ••• •••••••• • ••••• - Associated Therapies
- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- International/Other Brands
- Protargol
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Coldargan Lösung Silver proteinate (250 mg/10mL) + Ephedrine levulinate (200 mg/10mL) Solution / drops Nasal; Oral Sigmapharm Arzneimittel Gmb H 1961-03-20 Not applicable Austria 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- 9015-51-4
References
- General References
- AIFA Product Information: ARGENTO PROTEINATO ZETA (silver proteinate) nasal [Link]
- External Links
- Wikipedia
- Silver_proteinate
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution / drops Nasal Solution / drops Nasal; Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 17, 2020 21:56 / Updated at May 05, 2021 20:32